TM38837

CB1 antagonist 4 is a inverse agonist of cannabinoid receptor 1 (CB1) with an IC50 of 0.4 nM. CB1 antagonist 4 can reduce body weight, improve plasma inflammatory markers and glucose homeostasis[1].

Product Specifications

CAS Number

[1034264-77-1]

UNSPSC

12352005

Target

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/tm38837-1.html

Solubility

10 mM in DMSO

Smiles

FC(F)(C1=CC=C([C@@H](C)NC(C2=NN(C3=CC=CC=C3Cl)C(C4=CC=C(Cl)C=C4)=C2CC5=NNN=N5)=O)C=C1)F

Molecular Formula

C27H20Cl2F3N7O

Molecular Weight

586.40

References & Citations

[1]Högberg T, et al. Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837. Bioorg Med Chem Lett. 2023 Dec 1;98:129572.